TH1801000919A - Hydroxytriacine Compounds and Their Medical Uses - Google Patents
Hydroxytriacine Compounds and Their Medical UsesInfo
- Publication number
- TH1801000919A TH1801000919A TH1801000919A TH1801000919A TH1801000919A TH 1801000919 A TH1801000919 A TH 1801000919A TH 1801000919 A TH1801000919 A TH 1801000919A TH 1801000919 A TH1801000919 A TH 1801000919A TH 1801000919 A TH1801000919 A TH 1801000919A
- Authority
- TH
- Thailand
- Prior art keywords
- compounds
- hydroxytriacine
- disease
- medical uses
- page
- Prior art date
Links
Abstract
บทสรุปการประดิษฐ์ซึ่งจะปรากฏบนหน้าประกาศโฆษณาReadFile:หน้า1ของจำนวน1หน้าบทสรุปการประดิษฐ์การประดิษฐ์นี้จัดให้สารประกอบที่มีmPGES-1อินฮิบิทอรีแอคติวิตีและที่เป็นประโยชน์สำหรับการป้องกันหรือการบำบัดความเจ็บปวด,ไข้รูมาติก,โรคข้อต่อเสื่อม,ไข้,โรคอัลไซเมอร์,โรคปลอกประสาทเสื่อมแข็ง,ภาวะหลอดเลือดแดงแข็ง,ต้อหิน,ความดันสูงในลูกตา,โรคเรตินาหลอดเลือดอุดตัน,โรคหนังแข็งทั่วตัวและ/หรือมะเร็งซึ่งรวมถึงมะเร็งลำไส้การประดิษฐ์นี้เกี่ยวกับสารประกอบของสูตร[I-a],[I-b]หรือ[I-c]หรือเกลือของมันที่เป็นที่ยอมรับเชิงเภสัชกรรม:ที่ซึ่งแต่ละสัญลักษณ์เป็นตามที่นิยามไว้ในรายละเอียด Invention Summary, which appears on the ReadFile:1 page of the Invention Summary page. This invention provides a compound that contains mPGES-1 inhibitors and is useful for defense. or therapy for pain, rheumatic fever, degenerative joint disease, fever, Alzheimer's disease, multiple sclerosis, atherosclerosis, glaucoma, intraocular pressure, retinal vascular disease scleroderma and/or cancer, including colon cancer. This invention relates to compounds of the formula [Ia], [Ib] or [Ic] or their salts that are pharmaceutically recognized: where each symbol as defined in detail
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH1801000919A true TH1801000919A (en) | 2021-04-26 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500265A1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| WO2017205536A3 (en) | Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer | |
| PH12016501651A1 (en) | Triazine compound and use thereof for medical purposes | |
| GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| MY176631A (en) | Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors | |
| PH12018500181A1 (en) | Hydroxytriazine compound and medical use thereof | |
| MX2015016771A (en) | Carbazole carboxamide compounds useful as kinase inhibitors. | |
| TN2017000158A1 (en) | Carbazole derivatives | |
| WO2016109217A3 (en) | Btk inhibitors | |
| MX2017005060A (en) | Tricyclic atropisomer compounds. | |
| WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
| CR20220096A (en) | THERAPEUTIC FUSION PROTEINS | |
| TH1801000919A (en) | Hydroxytriacine Compounds and Their Medical Uses | |
| TH165163A (en) | Substitutated Tetrahydrocarbazole And Carbasol Carbok Chavez Used as a deterrent to the kinase function. | |
| PL431613A1 (en) | Compound to be applied in the treatment, PERK kinase inhibitor and its application for prevention and treatment of neurodegenerative diseases dependent on endoplasmic reticulum stress | |
| TH1801003597A (en) | alkyldihydroquinoline sulfonamide compounds | |
| TH1701001291A (en) | A spirocyclic inhibitor of cathepsin C. | |
| TH1901002344A (en) | Novel naphthyridone derivatives and their use in the treatment of cardiac arrhythmias. | |
| TH1801000840A (en) | LSD1 inhibitor salt | |
| TH1701002216A (en) | Functional indolcarboxamides as inhibitors of kinase | |
| TH1901004238A (en) | HDAC6 selective inhibitor, method of preparation of that inhibitor and application of that inhibitor. | |
| TH182826A (en) | Thyazine compounds and their use for medical purposes | |
| TH1801000164A (en) | The substituted oxypyridine derivative | |
| TH1801007671A (en) | Pyrazobopyrimidin derivatives as inhibitors of kinase reactions. | |
| TH1801002448A (en) | Compound JAK kinase inhibitor for the treatment of respiratory disease. |